Atlantic Bone Screen is a leading CRO (« Contract Research Organization ») based in Nantes, in the north-west of France, specializing in high-quality preclinical evaluation services in the field of bone and joint diseases, and more particularly in bone diseases from tumor origin.
Atlantic Bone Screen is a spin-off of the Laboratory of physiopathology of bone resorption (LPRO) UMR 957 of the Faculty of Medicine in Nantes and relies on its recognized expertise developed in the field of bone diseases.
Created in 2005 by Ronan LE BOT, CEO, Atlantic Bone Screen puts at your disposal a unique preclinical platform with a wide range of competitive in vitro and in vivo assays as well as histology and imaging services.
More than 110 preclinical studies have been conducted by Atlantic Bone Screen since the creation of the company in 2005.
Research centers from the most important pharmaceutical and food industries as well as biomaterial companies trust Atlantic Bone Screen.
Our Missions
Atlantic Bone Screen aims to optimize and accelerate the development of your compounds, allowing you to identify and characterize the therapeutic potential of your drug candidates, nutraceuticals and biomaterials.
Our Values
Quality Management
Atlantic Bone Screen ISO 9001:2008 certificate
Our priority : Your full satisfaction through personalized solutions meeting high standards of quality and confidentiality.
Atlantic Bone Screen is committed to providing you with tailor-made solutions for your preclinical studies and a high-quality expertise to deliver results within a short time frame. All our studies are carried out according to a personalized protocol validated by you before its implementation. We respect ISO 9001v2008 requirements and apply Good Laboratory Practices (GLP). We plan on offering GLP-compliant studies by 2012.
Furthermore, Atlantic Bone Screen ensures strict confidentiality of client records (access exclusively reserved to Atlantic Bone Screen employees, specific codification for each project, performance of all protocols in-house, set up of confidentiality agreements).
All Atlantic Bone Screen technicians involved hold personal registered licenses. In vivo assays are performed according to specific procedures in registered animal facilities complying with current regulations.
High responsiveness and flexibility
Our commitment : A flexible and available team at your disposal at all times dedicated to providing a high level of responsiveness to meet your requirements.
Working in close collaboration with you, our team will think ahead of your needs in terms
of Research and Development in order for you to easily reach your scientific goals. We are
committed to providing you with a precise and quick reply.
Atlantic Bone Screen guarantees the observation of all standards required for the implementation
of preclinical studies: flexibility, quality and responsiveness.
Once your request is sent :
- Acknowledgement of receipt of your request
- Confidential code allocation
- Dedicated project manager allocation
- Study protocol and price quotation sent to the sponsor
- Communication with the project manager before final agreement
- Sending of the study plan
- Communication with the project manager before validation of the study plan
- Weekly follow-up of the study
- Sending of intermediate reports
- Organization of teleconferences
- Sending of the final report (with all generated data)
- Sending of the draft report
- Discussions
- Validation
- Sending of the final report in electronic and paper version.
Innovation
Our vision : Constant innovative services based on the latest scientific breakthroughs and on the continuous development of new specific preclinical models.
Atlantic Bone Screen sets up personalized experimental protocols meeting your scientific expectations thanks to a preclinical platform constantly sustained by in-house R&D projects. This platform enables us to validate and promote the compounds thanks to a wide range of relevant, groundbreaking and diversified in vitro and in vivo assays.
The company belongs to the network of biotechnology companies of the Atlanpole Biotherapies cluster. Therefore Atlantic Bone Screen has many partners whose services are complementary.
We thus have the chance to dispose of wide-ranging skills in the field of life sciences (www.atlanpolebiotherapies.com)
